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ORIGINAL RESEARCHThe Interaction of Depressive Symptoms and Hazardous
Drinking in Relation to Tobacco Craving Among Treatment
Seeking Depressed Smokers: Sex DifferencesRube´n Rodrı´guez-Cano, MA, Ana Lo´pez-Dura´n, PhD, Daniel J. Paulus, MA, Carmela Martı´nez-Vispo, MA,
Elena Ferna´ndez del Rı´o, PhD, Elisardo Becon˜a, PhD, and Michael J. Zvolensky, PhDObjectives: The present study sought to address whether there is sex
effect in the interactive effect between depressive symptoms and
hazardous drinking in the prediction of smoking craving after
cognitive-behavioral smoking cessation treatment among those with
at least mild depression.
Methods: Participants (n¼ 114, mean age 42.0, SD¼ 9.73, 64%
women) were treatment-seeking smokers who attended 6 weekly
1-hour sessions involving psychological treatment for cessation.
Participants reported depressive symptoms and alcohol use at base-
line and reported craving at baseline and after treatment.
Results: Results indicated that there was a statistically significant
3-way interaction (depression by alcohol use by sex) for smoking
craving (B¼0.30, standard error [SE]¼ 0.14, P¼ 0.042) and
appetitive craving (B¼.21, SE¼ 0.09, P¼ 0.031), but not negative
reinforcement craving. The form of the significant interactions
indicted that higher levels of depressive symptoms and alcohol
use were related to greater levels of craving at the end of treatment
only among men.
Conclusions: The current findings provide novel empirical evidence
suggesting that there is a clinically relevant interplay between
depressive symptoms and alcohol use regarding general cravingCopyright © 2017 American Society of Addiction Medicine. U
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Although the present results should be replicated in larger samples,
this type of research can inform the development of sex-specific
interventions for smoking cessation.
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T obacco use remains the leading preventable cause ofdeath and disability in developed countries (Lim et al.,
2012). More than 1 billion people smoke tobacco (World
Health Organization [WHO], 2017). Despite the reduction in
smoking incidence in certain areas of the world (United States
Department of Health and Human Services, 2014), smoking
relapse remains highly common. For example, nearly 70% of
smokers report a desire to quit smoking (USDHHS, 2014), but
more than 60% who receive smoking-cessation treatment
relapse within a year (Bauld et al., 2010).
Theory and research suggest craving, denoting the
subjective experience of desiring to smoke (Tiffany and Wray,
2012), is a core construct involved in the maintenance and
relapse of smoking. Craving is related to an increased likeli-
hood of smoking (Shiffman et al., 2013), cigarette dependence
(Carpenter et al., 2014), reduced likelihood of quitting (Pin˜e-
iro et al., 2014), and an increased likelihood of relapse (Allen
et al., 2008). Past work also indicates that craving is a
multidimensional construct, including the intention and desire
to smoke based on the anticipation pleasure derived from
cigarettes; and the anticipation of reduced negative affect
(Cox et al., 2001). Given the broad-based prominence of
craving in smoking maintenance and relapse (Wray et al.,
2013), there is a need to better understand factors that may
help identify variables associated with craving as a global and
multidimensional construct.
Depressed affect is 1 common and important public
health factor to consider in craving-tobacco relations. People
with compared to without clinical depression tend to smoke
more cigarettes on a daily basis (Ziedonis et al., 2008), have
greater cigarette dependence (Dierker and Donny, 2008), and
are more likely to relapse (Cooper et al., 2016). A recent
systematic review concluded that depressed smokers struggle
with smoking cessation and evince a greater appetitive value
to smoke in comparison to nondepressive smokers (Mathewnauthorized reproduction of this article is prohibited.
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smoking processes, such as craving, among smokers with
elevated depressive symptoms. Previous studies have reported
that smokers with greater depressive symptoms have higher
levels of craving than smokers with lower depressive symp-
toms (Reid and Ledgerwood, 2016). In addition, craving
partially explains the effect of depressive symptoms in terms
of smoking lapse (Brodbeck et al., 2014). Yet, because not all
smokers with depressive symptoms demonstrate greater crav-
ing (Leventhal et al., 2009), there is a need to identify the other
factors that explain why some smokers demonstrate greater
craving, whereas others do not (Brodbeck et al., 2014); such
for whom and under what conditions depressive symptoms are
related to craving.
Importantly, alcohol use is highly common among
smokers (Kahler et al., 2008) and may be 1 factor involved
in the depression-craving association among smokers. For
example, in the context of an integrated alcohol and smoking
treatment, Holt et al. (2012) found that participants with lower
positive mood and greater craving had greater likelihood of
smoking during the first days after quitting. Also, smokers
with higher depressive symptoms are more likely to engage in
hazardous drinking even when compared with nonsmokers
with similarly high levels of depressive symptoms (Lombar-
dero et al., 2014). Other research among older adult smokers
who were largely men (67%) suggests that alcohol problems
were a moderator of the relationship between depressive
symptoms and smoking cessation (Kenney et al., 2009).
Collectively, available work suggests clinically relevant, but
complex, relations may be evident between depressed affect,
craving, and alcohol use among smokers with elevated depres-
sive symptoms.
Negative-reinforcement motivational models of sub-
stance use (Baker et al., 2004) provide a useful conceptual
framework for better understanding craving in the context of
depressed affect and alcohol use. Specifically, greater
depressed affect may be related to more intense craving
(Leventhal et al., 2009), which, in turn, could be influenced
by alcohol use used to modulate such cognitive-affective
experiences (Bolton et al., 2009). Such a perspective would
lead to the prediction that the interaction of depressive
symptoms and alcohol use would be associated with smoking
craving severity among smokers with elevated depressive
symptoms. Given that smokers with higher depressive symp-
toms present greater craving (Reid and Ledgerwood, 2016),
exploring this interaction among smokers with higher depres-
sive symptoms would help to better understand the interplay
effect of depression and alcohol use in smoking craving.
Sex differences may help explain the relationship
between depressive symptoms, alcohol, and craving. Past
work has found that depressive symptoms and smoking co-
occurrence is more likely in women (Husky et al., 2008).
Furthermore, some work suggests depressive symptoms
among women relative to men may have a more detrimental
impact on smoking processes cessation (Weinberger et al.,
2013). Alcohol use also has been found to evince differences
among smokers in terms of sex. For example, alcohol use is
related to increased smoking urge and behavior in men, but
only urge among women (King et al., 2009). Likewise,Copyright © 2017 American Society of Addiction Medicine. U
2hazardous alcohol use has been found to have a greater effect
on relapse among men relative to women (Rodrı´guez-Cano
et al., 2016). Consistent with this work, research has found
that men demonstrate greater craving compared with women
after quitting (Pomerleau et al., 2005; Collins et al., 2011). In
another investigation, depressive symptoms and craving
severity interacted to predict relapse among women relative
to men (Rodrı´guez-Cano et al., 2017).
Together, the present study sought to address whether
there is a synergic effect of depressive symptoms and alcohol
use (pretreatment) in the prediction of smoking craving at
post-treatment among those reporting at least mild depressive
symptoms. We modeled the data as a function of sex, given
past work that suggests differences among women and men in
terms of smoking, depression, and alcohol use. We hypothe-
sized that among women with at least mild depressive symp-
toms, the interactive effect of depressive symptoms and
alcohol use would be related to greater post-treatment craving.
We also hypothesized that among men, this craving effect
would be less intense (ie, statistically smaller), as theoretically
there is lesser impact of depressive symptoms in smoking
among men (Weinberger et al., 2013).
METHODS
Participants
Individuals were 114 adult treatment-seeking smokers
who scored 14 and above on the Beck Depression Inventory
(BDI)-II at pretreatment (Beck et al., 1996) (mean age 42.0,
SD¼ 9.73, 64.0% women). They were selected from initial
sample of 493 smokers who received a group format cogni-
tive-behavioral treatment for smoking cessation and attended
to the end of treatment assessment. Excluded participants
(n¼ 379) did not show differences in covariates (age, marital
status, years of smoking, number of cigarette at pretreatment,
cigarette dependence) or predictors (sex and alcohol use). By
design, the study sample had higher depressive symptoms and
craving before treatment (general and appetitive craving) and
after treatment (general, appetitive craving, and negative
reinforcement craving).
Smokers were excluded if they were aged under 18,
participated in the same treatment or received pharmacologi-
cal treatment to quit smoking (nicotine replacement therapy,
varenicline, and/or bupropion) during the past year, presented
with psychosis or bipolar disorder, were dependent on a
substance other than cigarettes (determined via clinical inter-
view), or suffered a high-risk physical disease (eg, recent
cancer diagnosis).
Procedure
The research was approved and authorized by Bioethics
Committee of the University of Santiago de Compostela.
Participants were informed by written consent before starting
the study procedure. Next, they completed self-questionnaires
at pretreatment and participated in a pretreatment clinical
interview. They also completed Questionnaire Smoking Urges
(QSU)-brief at posttreatment. A 6-session cognitive-behav-
ioral smoking-cessation treatment (Becon˜a, 2007) was admin-
istered in a group format (6–8 participants). This treatmentnauthorized reproduction of this article is prohibited.
 2017 American Society of Addiction Medicine
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2014). Sessions occurred weekly. The treatment components
included tobacco use and general health information, nicotine
fading, strategies for craving, and nicotine withdrawal (eg,
reducing alcohol and coffee consumption), cigarette con-
sumption feedback by carbon monoxide (CO) in expired
air, and relapse prevention skills (eg, not accepting cigarettes
when others offer them). Treatment was delivered by Master
level psychologists. Abstinence at the end of treatment (sixth
session of treatment) was determined by self-report of not
having smoked, even a puff, in the 24 hours before the session,
and assessment of CO <5 (Perkins et al., 2013). Sixty-nine
participants (60.5% of the sample) quit smoking at the end
of treatment.
Measures
Smoking Habit Questionnaire
The Smoking Habit Questionnaire (SHQ) is a self-
report questionnaire that measures information about sex,
age, marital status, educational background, and smoking
history. The SHQ was administered before treatment (Becon˜a,
1994).
Fagerstro¨m Test for Cigarette Dependence,
Spanish version
The Fagerstro¨m Test for Cigarette Dependence (FTCD;
Fagerstro¨m, 2012 and its Spenish version Becon˜a and Va´z-
quez, 1998) is a 6-item self-report assessment of cigarette
dependence. Scores range from 0 to 10 (Heatherton et al.,
1991). Higher scores correspond to higher levels of physio-
logical cigarette dependence. In the current sample, the FTCD
demonstrated a Cronbach a of 0.56. The FTCD was adminis-
tered at pretreatment.
Beck Depression Inventory-II, Spanish Version
The BDI-II (Beck et al., 1996 and its Spanish version
Sanz and Va´zquez, 2011) is a multiple-choice 21-item self-
report questionnaire. Scores range from 0 to 63, with higher
scores reflecting greater depressive symptomatology in the
previous 2 weeks. Scores of 14 and above were used as cut-off
to indicate the presence of mild or greater depressive symp-
toms, as in past work with North American (Beck et al., 1996)
and Spanish (Sanz and Va´zquez, 2011; Sanz et al., 2014)
samples. The BDI-II demonstrated excellent internal consis-
tency in a prior study with Spanish population (Cronbach
a¼ 0.91; Sanz and Va´zquez, 2011). The BDI-II was admin-
istered before treatment.
Alcohol Use Disorder Identification Test, Spanish
Version
The Alcohol Use Disorder Identification Test (AUDIT)
(Saunders et al., 1993, Spanish version Contel et al., 1999) is a
10-item self-report scale that assesses hazardous alcohol
drinking. Scores range from 0 to 40. Items assess frequency,
quantity, symptoms of dependence, and harmful drinking. In
the current report, we used the term ‘‘hazardous drinking’’ to
refer to the AUDIT total score. This instrument has demon-
strated sound psychometric properties among SpanishCopyright © 2017 American Society of Addiction Medicine. U
 2017 American Society of Addiction Medicinesamples (Cronbach a¼ 0.88) (Contel et al., 1999). The
AUDIT was administered before treatment.
Questionnaire Smoking Urges-brief, Spanish
Version
The QSU-brief (Cox et al., 2001 and its Spanish version
Cepeda-Benito and Reigh-Ferrer, 2004) is a multidimensional
measure of current smoking craving. It is comprised of 10
self-report items with total scores ranging from 7 to 70.
Higher scores correspond to greater levels of craving. The
instrument produces a global craving score (QSU-Total) and 2
subfactors tapping appetite craving (QSU-Factor 1) (eg,
‘‘I want to smoke right now’’) and negative reinforcement
craving (QSU-Factor 2) (eg, ‘‘I will feel less depressed if I
smoke’’). This instrument has good reliability (Cox et al.,
2001), which has been replicated among Spanish samples
(Cepeda-Benito and Reigh-Ferrer, 2004). The QSU was
administered at pre and post-treatment. In the current study,
the QSU-brief demonstrated good internal consistency (pre-
Cronbachs a¼ 0.85; post-Cronbach a¼ 0.90).
Microþ Smokerlyzer (Bedfont Scientific Ltd, Sitting-
bourne, UK) was used to measure carbon monoxide (CO) in
expired air. CO was used to validate smoking.
Data Analyses
Variables in the study were normally distributed (skew-
ness j0.11–2.54j and kurtosis j0.17–7.71j). Multivariate out-
liers were identified with Mahalanobis test (n¼ 2) and
removed from analysis.
First, descriptive statistics and 0-order correlation were
calculated to examine the association between study variables
(sex, age, marital status, years smoking, number of cigarettes
per day at pretreatment, cigarette dependence, depressive
symptoms, hazardous drinking, and craving pre and post-
treatment). Then, the interactive effects of sex, depressive
symptoms, and hazardous drinking were tested using 3 hier-
archical regression models to study the change in variance
(measured by the increasing of R square), one for each
smoking post-treatment craving-dependent variable. Analy-
ses were conducted with the PROCESS Macro (Hayes and
Preacher, 2014), using IBM SPSS version 23.0. In step 1, age,
marital status, years smoking, number of cigarettes per day at
pretreatment, cigarette dependence, and pretreatment levels
of the smoking craving were included. The second step
included the main effects of sex, depressive symptoms, and
hazardous drinking entered simultaneously. The third step
included three 2-way interaction terms (depressive symp-
toms sex, depressive symptoms hazardous drinking, haz-
ardous drinking sex). Finally, the 3-way interaction term
was added in the fourth step.
When the 3-way interaction was statistically significant,
follow-up tests were conducted to evaluate whether the inter-
action of depressive symptoms (X) and hazardous drinking
(M) was significantly different between men (W¼ 0) and
women (W¼ 1). Then, post hoc analyses were run separately
in men and women for significant interactions using simple
slopes to examine the effect of depressive symptoms on
craving at high versus low (1 SD from the mean) levels
of alcohol use (M). Furthermore, the Johnson-Neymannauthorized reproduction of this article is prohibited.
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regions of significance (ie, levels of hazardous drinking),
where depressive symptoms are associated with smoking
craving. This technique was selected because is more specific
than selected an arbitrary value (as in ‘‘pick-a-point’’ method
used for simple slopes; Hayes, 2013). Regression weights and
standard errors were reported.
RESULTS
Descriptive Statistics and Zero-order
Associations
Slightly more than half of the participants were married
(n¼ 58, 50.9%). Less than half reported completing more than
high school (n¼ 44; 38.6%), with 41.2% (n¼ 47) completing
high school and 20.2% (n¼ 23) completing less than high
school. The sample included regular smokers who smoked
for 24.2 years (SD¼ 10.33), smoked an average of 21.6
(SD¼ 8.8) cigarettes per day, scored an average of 25.12
(SD¼ 12.12) in CO in expired air, and presented with moderate
cigarette dependence, scoring an average of 5.36 (SD¼ 2.16)
on the FTCD (Heatherton et al., 1991) pretreatment.
Descriptive statistics and differences by sex are dis-
played in Table 1. Men were less likely to quit (68.0% women
vs 46.3% men) and reported significantly greater pretreatment
number of cigarettes, less pretreatment depressive symptoms,
and higher hazardous drinking than women.
Correlations indicated a positive relation between being
women and negative reinforcement craving (pretreatment),Copyright © 2017 American Society of Addiction Medicine. U
TABLE 1. Demographics, Smoking History, and Study Variables
Total
(N¼ 114)
Female
(n¼ 73)
n % n %
Marital status
Single 56 49.1 36 49
Married 58 50.9 37 63
Educational level
Lower high school 23 20.2 17 23
High school 47 41.2 25 34
More high school 44 38.6 31 42
Smoking status end of treatment
Abstinent 69 60.5 50 68
Smokers 45 39.5 23 31
M SD M SD
Age 42.03 9.7 42.56 9.6
CO level 25.12 12.1 25.00 12.5
Years smoking 24.18 10.3 24.26 10.2
CPD 21.63 8.8 20.29 7.5
FTCD 5.36 2.2 5.30 2.2
BDI-II 21.9 7.3 23.63 7.7
AUDIT 3.17 3.8 2.26 2.7
QSU-Total pretreatment 32.98 12.8 34.21 14.0
QSU-Factor 1 pretreatment 21.22 8.1 21.30 8.5
QSU-Factor 2 pretreatment 11.76 6.7 12.90 7.6
QSU-Total post-treat. 19.68 11.7 20.05 11.8
QSU-Factor 1 post-treat. 11.73 7.8 12.04 7.9
QSU-Factor 2 post-treat. 7.95 5.0 8.01 5.2
AUDIT, Alcohol Use Disorders Identification Test total pretreatment score; BDI-II, Beck
cigarettes per day at pretreatment; FTCD, Fagerstro¨m Test for Cigarette Dependence pretre
craving; QSU-Total score, Questionnaire Smoking Urges.
4depression, and alcohol use. Depressive symptoms were
negatively related to hazardous drinking. Craving (pretreat-
ment) was positively related to all post-treatment craving
variables (see Table 2).
Interactive Effect Analyses
Results from hierarchical regression analyses are
reported in Table 3.
Global Craving (QSU-Total)
For the model estimating post-treatment global craving,
the 3-way interaction of sex by depression by hazardous
drinking was significant (B¼0.30, standard error
[SE]¼ 0.14, P¼ 0.042). The effect of depressive symptoms
in relation to global craving was moderated by hazardous
drinking in men (B¼ 0.28, SE¼ 0.11, P¼ 0.009), but not in
women (B¼0.01, SE¼ 0.10, P¼ 0.879) (Fig. 1). Follow-up
analyses among men (n¼ 41) showed that depressive symp-
toms were only related to craving at higher levels of hazardous
drinking (B¼ 1.99, SE¼ 0.49, P< 0.001). Finally, the John-
son-Neyman technique revealed that depressive symptoms
were positively associated with craving (B¼ 0.46, SE¼ 0.23,
P< 0.05) for AUDIT scores of 2.62 or higher (representing
51.22% of the sample; Fig. 2).
Appetitive Craving (QSU-Factor 1)
Regarding posttreatment craving for appetitive reasons,
the 3-way interaction of sex by depression by hazardous
drinking was significant (B¼0.21, SE¼ 0.09, P¼ 0.031).nauthorized reproduction of this article is prohibited.
By Sex (N¼114)
Male
(n¼ 41)
N % x2 P Cramer V
0.003 0.956 0.005
.1 20 48.8
.8 21 51.2
4.161 0.125 0.191
.3 6 14.6
.2 22 53.7
.5 13 31.7
5.392 0.020 0.217
.5 19 46.3
.5 22 53.7
M SD t P Cohen d
41.07 10.0 0.782 0.436 0.153
25.34 11.6 0.144 0.886 0.028
24.05 10.6 0.104 0.917 0.020
24.02 10.5 2.208 0.029 0.431
5.46 2.1 0.383 0.702 0.075
18.83 5.2 3.964 <0.001 0.774
4.78 4.8 3.113 0.003 0.608
30.80 9.9 1.502 0.136 0.293
21.07 7.48 0.576 0.566 0.112
9.73 4.3 0.189 0.850 0.037
19.00 11.6 0.460 0.645 0.090
11.17 7.7 0.571 0.569 0.111
7.83 4.7 0.462 0.645 0.090
Depression Inventory second version pretreatment score; CO, carbon monoxide; CPD,
atment score; QSU-Factor 1, appetitive craving; QSU-Factor 2, negative reinforcement
 2017 American Society of Addiction Medicine
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TABLE 2. Descriptive Statistics and Bivariate Correlations Among Study Variables (N¼114)
1 2 3 4 5 6 7 8 9 10 11 12 13
1. Agea —
2. Marital statusa 0.35 —
3. Years smokinga 0.86 0.35y —
4. CPDa 0.18 0.08 0.22y —
5. FTCDa 0.13 0.09 0.20y 0.67 —
6. Sexb 0.07 0.01 0.01 0.20y 0.04 —
7. BDI-IIb 0.23y 0.06 0.22y 0.03 0.18 0.32 —
8. AUDITb 0.16 0.10 0.12 0.03 0.07 0.32 0.26 —
9. QSU-Total score-pretreatmenta 0.07 0.01 0.10 0.20 0.19y 0.13 0.19y 0.07 —
10. QSU-Factor 1 pretreatmenta 0.01 0.00 0.10 0.17 0.14 0.01 0.08 0.01 0.89 —
11. QSU-Factor 2 pretreatmenta 0.12 0.01 0.07 0.17 0.20y 0.23y 0.26 0.12 0.83 0.47 –
12. QSU-Total score post-treatmentc 0.07 0.07 0.01 0.06 0.07 0.04 0.10 0.13 0.31 0.27 0.27 —
13. QSU-Factor 1 post-treatmentc 0.13 0.10 0.09 0.08 0.12 0.05 0.03 0.10 0.30 0.28 0.23y 0.95 —
14. QSU-Factor 2 post-treatmentc 0.03 0.01 0.10 0.02 0.25 0.18 0.18 0.15 0.27 0.20y 0.28 0.87 0.67
Note: Superscript alphabet ‘a’ denotes covariates; ‘b’ predictors; and ‘c’ dependent variables.
Marital status, coded as single¼ 0, married¼ 1.
Numbers across on the top correspond with variables numbered 1–13.
AUDIT, Alcohol Use Disorders Identification Test total pretreatment score; BDI-II, Beck Depression Inventory second version pretreatment score; CPD, cigarettes per day at
pretreatment; FTCD, Fagerstro¨m Test for Cigarette Dependence pretreatment score; Sex, coded female as 1; QSU-Factor 1, appetitive craving; QSU-Factor 2, negative reinforcement
craving; QSU-Total score, Questionnaire Smoking Urges.
P< 0.01.
yP< 0.05.
TABLE 3. Hierarchical Regression Analysis (Main and Interactive Effects of Depressive Symptoms, Alcohol Use, and Sex in
Relation to Post-treatment Craving (N¼114)
Step Predictor B SE t P R2 Changse
QSU-Total score
1 Age 0.284 0.22 1.315 0.191 0.120
Marital status 1.798 2.27 0.792 0.430
Years smoking 0.283 0.21 1.376 0.172
CPD 0.013 0.16 0.077 0.938
FTCD 0.130 0.67 0.194 0.846
QSU-TS pretreatment 0.292 0.09 3.435 0.001
2 Sex 2.036 2.46 0.827 0.410 0.056
BDI-II 0.281 0.16 1.745 0.084
AUDIT 0.518 0.30 1.725 0.088
3 BDI-II sex 0.833 0.40 2.067 0.041 0.067
AUDIT sex 1.069 0.69 1.547 0.125
BDI-IIAUDIT 0.119 0.07 1.641 0.104
4 BDI-IIAUDIT sex 0.295 0.14 2.062 0.042 0.031
QSU-Factor 1
1 Age 0.224 0.15 1.536 0.127 0.112
Marital status 1.108 1.52 0.731 0.466
Years smoking 0.164 0.14 1.182 0.240
CPD 0.046 0.11 0.415 0.679
FTCD 0.409 0.45 0.918 0.361
QSU-F1 pretreatment 0.275 0.09 3.074 0.003
2 Sex 1.688 1.66 1.019 0.310 0.145
BDI-II 0.107 0.11 0.988 0.326
AUDIT 0.321 0.20 1.581 0.117
3 BDI-II sex 0.491 0.27 1.787 0.077 0.203
AUDIT sex 0.698 0.46 1.502 0.136
BDI-IIAUDIT 0.076 0.05 1.544 0.126
4 BDI-IIAUDIT sex 0.213 0.09 2.186 0.031 0.036
QSU-Factor 2
1 Age 0.071 0.09 0.759 0.450 0.108
Marital status 0.620 0.97 0.637 0.525
Years smoking 0.124 0.09 1.409 0.162
CPD 0.038 0.07 0.547 0.586
FTCD 0.235 0.29 0.815 0.417
QSU-F2 pretreatment 0.213 0.07 3.063 0.003
2 Sex 0.541 1.05 0.514 0.608 0.074
BDI-II 0.161 0.07 2.344 0.021
AUDIT 0.196 0.13 1.541 0.126
3 BDI-II sex 0.339 0.17 1.980 0.050 0.061
AUDIT sex 0.453 0.30 1.521 0.131
BDI-IIAUDIT 0.048 0.03 1.561 0.122
4 BDI-IIAUDIT sex 0.080 0.06 1.302 0.196 0.013
Note: Marital status coded as single¼ 0, married¼ 1.
AUDIT, Alcohol Use Disorders Identification Test total pretreatment score; BDI-II, Beck Depression Inventory second version pretreatment score; CPD, cigarettes per day at
pretreatment; FTCD, Fagerstro¨m Test for Cigarette Dependence pretreatment score; sex, female coded by 1; QSU-Factor 1, appetitive craving; QSU-Factor 2, negative reinforcement
craving; QSU-Total score, Questionnaire Smoking Urges. Three-way interaction¼BDI-IIAUDIT sex.
P< 0.05.
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smoking craving was moderated by hazardous drinking in
men (B¼ 0.19, SE¼ 0.07, P¼ 0.009), but not in women
(B¼0.02, SE¼ 0.07, P¼ 0.759) (see Fig. 3). Follow-up
analyses among men (n¼ 41) showed that depressive symp-
toms were related to appetitive craving at higher hazardous
drinking scores (B¼ 2.00, SE¼ 0.49, P< 0.001). Johnson-
Neyman technique results indicated that depressive symptoms
were positively associated with appetitive craving (B¼ 0.46,
SE¼ 0.23, P< 0.05) for AUDIT scores of 2.63 or higher
(representing 51.22% of the sample; Fig. 2).
Negative Reinforcement (QSU-Factor 2)
For post-treatment negative reinforcement craving, the
3-way interaction was not significant (B¼0.08, SE¼ 0.06,
P¼ 0.196). Only pretreatment negative reinforcement cravingCopyright © 2017 American Society of Addiction Medicine. U
FIGURE 1. Conditional effect of depressive symptoms (BDI-II)
on general craving (QSU-Total scores) in terms of levels of
alchol use (AUDIT). The male interaction is represented in
upper chart. The female interaction is represented in lower
chart. AUDIT, Alcohol Use Disorders Identification Test total
pretreatment score; BDI-II, Beck Depression Inventory 2nd
version pretreatment score; QSU, Questionnaire Smoking
Urges post-treatment scores.
FIGURE 2. Area of significant conditional effect of pretreat-
ment depressive symptoms (BDI-II) on general (QSU-Total
scores; upper chart) and appetitive posttreatment smoking
craving (QSU-Factor 1; lower chart) by pretreatment alcohol
use scores (AUDIT) in males with at least mild depressive
symptoms (n¼41). Note: Solid black line displays the condi-
tional effect at AUDIT scores. Dot lines display 95% confidence
interval for the effect. Shadowed area displays the significant
association of BDI-II and QSU at AUDIT scores. AUDIT, Alcohol
Use Disorders Identification Test total pretreatment score; BDI-
II, Beck Depression Inventory 2nd version pretreatment score;
QSU, Questionnaire Smoking Urges post-treatment scores.
6accounted for significant variance (B¼ 0.21, SE¼ 0.07,
P¼ 0.003). Finally, lower depression (B¼0.16, SE¼ 0.13,
P¼ 0.021) was the only main effect significantly related to
post-treatment negative reinforcement craving.
DISCUSSION
The present study examined the interactive effects of
depressive symptoms and hazardous drinking in relation to
craving among treatment-seeking smokers with heightened
depressive symptoms in the context of sex. Results were
partially in accord with a priori prediction. The interactive
effect of depressive symptoms and hazardous drinking at
pretreatment was related to craving at post-treatment only
among men. These findings extend past work that has focused
in the individual effects of depressive symptoms (Reid and
Ledgerwood, 2016) and hazardous drinking (Kahler et al.,nauthorized reproduction of this article is prohibited.
 2017 American Society of Addiction Medicine
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FIGURE 3. Conditional effect of depressive symptoms (BDI-II)
on appetitive craving (QSU-Factor 1) in terms of levels of alchol
use (AUDIT). Themale interaction is represented in upper chart.
The female interaction is represented in lower chart. AUDIT,
Alcohol Use Disorders Identification Test total pretreatment
score; BDI-II, Beck Depression Inventory 2nd version pretreat-
ment score; QSU, Questionnaire Smoking Urges post-treat-
ment scores.
J Addict Med  Volume 00, Number 00, Month/Month 2017 Smoking, Sex, Craving, Depression, Hazardous Drinking2014) in relation to craving. The form of the interactions
showed that higher depressive symptoms were positively
related to greater global craving and appetitive craving among
men with greater hazardous drinking. Specifically, this inter-
active relationship was evident when mild depressed smokers
scored over 2 on alcohol use problems. Despite the low overall
level of hazardous drinking in the sample, our results are in
line with past work that has found that low level hazardous
drinking is related to greater craving (Oliver et al., 2013).
Clinically, the results suggest that hazardous drinking is a
possibly important variable to consider in relation to craving
among male treatment-seeking smokers with at least mild
depressive symptoms.
Interestingly, there was no interactive effect for negative
reinforcement craving among men. Such results are consistent
with other research that has found depressive symptoms were
not related to negative reinforcement craving (Leventhal et al.,Copyright © 2017 American Society of Addiction Medicine. U
 2017 American Society of Addiction Medicine2009). Theoretically, these findings might be explained by
incentive learning (Mathew et al., 2017), wherein depressive
smokers anticipate the positive effect of nicotine on their
mood (Cook et al., 2007). The present results expand past
work showing that alcohol use may be related to increased
appetitive craving (Shiffman et al., 2013) and may be more
relevant in men than in women (Rodrı´guez-Cano et al., 2016).
There was no interactive effect of depressive symptoms
and hazardous drinking on craving among women. Previous
work suggests depressive symptoms generally have a greater
influence on smoking maintenance and relapse among women
(Weinberger et al., 2013). However, given that past work has
documented that hazardous drinking has a greater effect on
smoking among men than in women in Spanish-speaking
populations from Europe (Rodrı´guez-Cano et al., 2016), it is
possible that alcohol does not operate as a moderator among
women universally (ie, across countries/cultures). Future
research may benefit from exploring the interaction of depres-
sive symptoms and hazardous drinking in relation to craving
among male smokers from other countries. Such work also
could examine other moderator variables such as social
context and social support (King et al., 2009).
There are several study limitations. First, there was a
relatively small sample of men in the study. Thus, future work
should replicate and extend the present findings to larger
treatment-seeking smoking samples balanced by sex. Second,
participants with mild depressive symptoms included in the
current analyses represented 23% of the total sample. Future
research may benefit from exploring more severe samples,
including smokers with clinical depression. Third, we did not
assess the nature of depression and hazardous drinking during
smoking-cessation treatment. Future research should there-
fore explore how these factors interplay with one another
during smoking-cessation treatment. Finally, although the
present study evaluated pretreatment depression and alcohol
in relation to post-treatment craving and controlled for pre-
treatment levels of craving, causal inferences cannot be
drawn. Future work should evaluate the present model with
multiple observations.
CONCLUSIONS
The present findings suggest that there may be clinical
utility to better understanding sex differences in the context of
depressive symptoms, hazardous drinking, and craving among
treatment-seeking smokers with at least mild depressive
symptoms. Future research may benefit from developing
sex-specific intervention programming for smoking cessation
to help in the clinical management of craving.
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